MACK(Delisted)
MerrimackยทNASDAQ
--
--(--)
MACK Profile
Merrimack Pharmaceuticals, Inc.
A biopharmaceutical company that develops pharmaceuticals and companion diagnostics for the treatment of cancer and other serious diseases
One Broadway, 14th Floor, Cambridge, MA 02142
--
Merrimack Pharmaceuticals, Inc. The company was incorporated in the Commonwealth of Massachusetts in 1993 and reorganized in Delaware in October 2010. Is a biopharmaceutical company engaged in the discovery, development and preparation of commercialized innovative drugs (including novel companion diagnostic therapies). The company has six clinical-stage tumor targeting product candidates (MM-398, MM-121, MM-111, MM-302, MM-151 and MM-141) and multiple product candidates in preclinical development, and is committed to driving the discovery of more drug candidates. Its research and development work is driven by network biology, which is a special discipline for biomedical research based on biology.
